Replies to post #305472 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

I can only say I hope so but I dont think so.

Lets make a distinction here between for example a new DCVAX trial/study for lung and liver (for example!) after the approval for GBM.

Physicians are awful stubborn. They will tell the patient that DCVAX has been approved for GBM and not for ... cancer So if a patient want to participate in the lung/liver trial/study Im sure the physician will support the patient with the enlisting. If the patient has colon cancer and for example, there is no DCVAX colon cancer study (for example) then NWBO nor the physician can help the patient with that request.

Until DCVAX is approved for all organs and NWBO is worth over $1000 billion if that happens.